These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2575663

  • 21. Effects of inhaled KAA-276, a selective histamine H1 receptor antagonist, on antigen- and histamine-induced bronchoconstriction in animals.
    Kobayashi T, Takehana Y, Shinagawa K, Tsuyuki S, Tokutake Y, Sato M, Momose D.
    Arzneimittelforschung; 1998 Aug; 48(8):826-31. PubMed ID: 9748711
    [Abstract] [Full Text] [Related]

  • 22. Comparative study of various H1-blockers on neuropharmacological and behavioral effects including 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate (KB-2413), a new antiallergic agent.
    Tasaka K, Kamei C, Katayama S, Kitazumi K, Akahori H, Hokonohara T.
    Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):275-91. PubMed ID: 2872864
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects.
    Strenkoski-Nix LC, Ermer J, DeCleene S, Cevallos W, Mayer PR.
    Am J Health Syst Pharm; 2000 Aug 15; 57(16):1499-505. PubMed ID: 10965395
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
    Supko JG, Garcia-Carbonero R, Puchalski TA, Malspeis L.
    Cancer Chemother Pharmacol; 2001 Sep 15; 48(3):202-8. PubMed ID: 11592341
    [Abstract] [Full Text] [Related]

  • 28. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Oct 15; 43(10):1084-94. PubMed ID: 8267675
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The pharmacokinetics and bioavailability of clemastine and phenylpropanolamine in single-component and combination formulations.
    Schran HF, Petryk L, Chang CT, O'Connor R, Gelbert MB.
    J Clin Pharmacol; 1996 Oct 15; 36(10):911-22. PubMed ID: 8930778
    [Abstract] [Full Text] [Related]

  • 31. Antiasthmatic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413), a new antiallergic.
    Fukuda T, Saito T, Ito K.
    Arzneimittelforschung; 1984 Oct 15; 34(7):811-5. PubMed ID: 6149755
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Influence of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413), a new antiallergic, on ciliary movement.
    Fukuda T, Saito T, Yoshidomi M, Ito K.
    Arzneimittelforschung; 1984 Oct 15; 34(7):816-8. PubMed ID: 6149756
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species.
    Zhong CC, Chen F, Yang JL, Jia WW, Li L, Cheng C, Du FF, Zhang SP, Xie CY, Zhang NT, Olaleye OE, Wang FQ, Xu F, Lou LG, Chen DY, Niu W, Li C.
    Acta Pharmacol Sin; 2018 Jun 15; 39(6):1048-1063. PubMed ID: 29620050
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 2nd communication: Effects on the circulation and the other systems.
    Saito T, Fukuda T, Tajima S, Sukamoto T, Yamashita A, Kanazawa T, Morimoto Y, Shimohara K, Nishimura N, Yokota K.
    Arzneimittelforschung; 1988 Feb 15; 38(2):267-72. PubMed ID: 2897196
    [Abstract] [Full Text] [Related]

  • 38. Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats.
    Pelser A, Müller DG, du Plessis J, du Preez JL, Goosen C.
    Biopharm Drug Dispos; 2002 Sep 15; 23(6):239-44. PubMed ID: 12214324
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics and pharmacodynamics of d-chlorpheniramine following intravenous and oral administration in healthy Thoroughbred horses.
    Kuroda T, Nagata S, Takizawa Y, Tamura N, Kusano K, Mizobe F, Hariu K.
    Vet J; 2013 Aug 15; 197(2):433-7. PubMed ID: 23489843
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL, Vincent SH, Miller RR, Colletti AE, Alvaro RF, Wallace MA, Feeney WP, Chiu SH.
    Drug Metab Dispos; 1997 Oct 15; 25(10):1113-8. PubMed ID: 9321512
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.